Filter
1319
Filtered Results: 1319
Text search:
Pharmacology
Featured
Recommendations
150
New Publications
247
Language
Document type
No document type
676
Guidelines
252
Studies & Reports
201
Manuals
79
Strategic & Response Plan
33
Fact sheets
32
Training Material
28
Situation Updates
7
Resource Platforms
5
Brochures
2
Infographics
2
Online Courses
2
Countries / Regions
India
87
Global
57
South Africa
41
Kenya
32
Western and Central Europe
31
Ethiopia
21
Latin America and the Carribbean
18
Nigeria
17
Russia
15
Nepal
14
Rwanda
14
Ukraine
14
Africa
14
Uganda
13
Germany
13
Eastern Europe
13
Sierra Leone
12
Syria
11
Ghana
10
Zimbabwe
10
Tanzania
10
Brazil
10
Congo, Democratic Republic of
9
Philippines
9
Zambia
9
Bangladesh
9
Asia
8
Indonesia
7
Malawi
7
Eswatini/ Swaziland
7
Cameroon
6
Burkina Faso
5
Senegal
5
South Sudan
5
Mozambique
5
Namibia
5
Lesotho
5
Myanmar / Burma
5
South–East Asia Region
5
USA
4
Haiti
4
Argentina
4
Botswana
4
Madagascar
4
Liberia
3
Iraq
3
Angola
3
East and Southern Africa
3
West and Central Africa
3
Eastern Europe and Central Asia
3
Guinea
2
Guinea-Bissau
2
Papua New Guinea
2
Benin
2
Peru
2
North Macedonia
2
Ecuador
2
Chile
2
Middle East and North Africa
2
Western Pacific Region
2
Canada
2
Tajikistan
2
North America
2
Jamaica
2
Mali
1
Pakistan
1
Jordan
1
Afghanistan
1
Lebanon
1
Cambodia
1
Thailand
1
China
1
Ireland
1
Singapore
1
Sudan
1
Central African Republic
1
Hungary
1
Bolivia
1
Sri Lanka
1
Paraguay
1
Fiji
1
Bhutan
1
Poland
1
Mongolia
1
Southern Africa
1
Lithuania
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Gabon
1
Turkmenistan
1
France
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
406
Clinical Guidelines
164
Public Health
93
Women & Child Health
56
Pharmacy & Technologies
19
Capacity Building
11
Key Resources
6
Toolboxes
Mental Health
331
Pharmacy
101
AMR
83
NCDs
81
COVID-19
80
Caregiver
55
HIV
49
TB
48
NTDs
28
Conflict
19
Rapid Response
18
Planetary Health
15
Refugee
12
Disability
11
Ebola
10
Specific Hazards
8
Global Health Education
8
Natural Hazards
4
Zika
3
Polio
2
Social Ethics
2
Health Financing Toolbox
2
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu...
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD), along with evidence-based
solutions to overcome...
Prevention of stroke and transient ischemic attack includes both conventional approaches to vascular risk factor management (blood pressure lowering, cholesterol reduction with statins, smoking cessation and antiplatelet therapy)
and more specific interventions, such as carotid revascularization or...
This paper explores the angles and opportunities of digital health, with a look
at digital innovation and its potential to support patients with circulatory diseases.
In reviewing developments in the field, current applications as well as gaps, the paper aims to support policymakers in leveraging ...
Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr...
In 2012, all Member States of the World Health Organization (WHO) endorsed a historical target to reduce premature mortality from noncommunicable diseases
(NCD). This commitment was echoed in 2015 by the United Nations Sustainable Development Goals, which included a target to reduce premature morta...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable diseases (NCDs) worldwide. There is currently
an epide...
Buruli ulcer (BU) is a bacterial skin infection that is caused by Mycobacterium ulcerans and mainly affects people who reside in the rural areas of Africa and in suburban and beach resort communities in Australia.
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients wit...
Myocardial infarctions are generally clinically classified into ST elevation MI (STEMI) and non-ST elevation MI (NSTEMI), based on changes in ECG. When blood flow to a part of the heart stops or the heart is injured and fails to receive enough oxygen required for its adequate functioning the conditi...
Socioeconomic status is associated with differences in risk factors for cardiovascular disease incidence and outcomes, including mortality. However, it is unclear whether the associations between cardiovascular disease and common measures of socioeconomic status—wealth and education—differ among...
Background
Low- and middle-income countries now experience the highest prevalence and mortality rates of cardiovascular disease.
Main text
While improving the availability and delivery of proven, effective therapies will no doubt mitigate this burden, we posit that studies evaluating cardiovasc...
Evidence-based psychological interventions are an important part of health, social, protection and education services and can help increase access to effective mental health treatments and progression towards universal health coverage.
This manual provides managers and others responsible for plan...
While epidemiological data for type 1 diabetes (T1D) in low/middle-income countries, and particularly low-income countries (LICs) including Liberia is lacking, prevalence in LICs is thought to be increasing. T1D care in LICs is often impacted by challenges in diagnosis and management. These challeng...
The Resolution Population and Individual Approaches to the Prevention and Management of Diabetes and Obesity was approved by the 48th Directing Council of the Pan American Health Organization, September 29- October 3, 2008, in response to the epidemic of obesity and diabetes currently affecting the ...
This is an update (third edition) of the BACPR Standards & Core Components and represents current evidence-based best practice and a pragmatic overview of the structure and function of Cardiovascular Prevention and Rehabilitation Programmes (CPRPs) in the UK. The previously described seven standards...
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, genera...
